4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-024126
Director sold 1,666 shares at an average $56.42 ($93,992)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SATO VICKI L Director | 2021-03-31 | Sale | −18 | $54.38 | $979 | 139,069 | D |
| SATO VICKI L Director | 2021-03-31 | Sale | −877 | $55.91 | $49,034 | 138,192 | D |
| SATO VICKI L Director | 2021-03-31 | Sale | −635 | $56.92 | $36,145 | 137,557 | D |
| SATO VICKI L Director | 2021-03-31 | Sale | −136 | $57.61 | $7,834 | 137,421 | D |
| Open-market sales · 1,666 sh · avg $56.42 · $93,992 | |||||||
Loading xslF345X03/doc4.xml…